Clinical Trial Update: A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy

View source ↗

Summary

A completed clinical trial comparing dementia and Alzheimer's disease incidence in participants initiating methotrexate versus those starting anti-TNF therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Anti-TNF-alpha therapy
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Dementia, Alzheimer Disease | Status: COMPLETED